1.
Voskaridou E, Anagnostopoulos A, Konstantopoulos K, Stoupa E, Spyropoulou E, Kiamouris C, Terpos E. Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial. Haematologica [Internet]. 2006Sep.1 [cited 2026Nov.13];91(9):1193-202. Available from: https://haematologica.org/article/view/4145